Literature DB >> 26815566

The Influence of Bone Cement Implantation in Primary Hip Arthroplasty on S100B Protein Serum Concentration and Patients' Cognitive Functions as Markers of Brain Damage.

Dariusz Tomaszewski1,2, Zbigniew Rybicki3, Marcin Możański3.   

Abstract

OBJECTIVE: The objective of the study was to evaluate the influence of the bone cement used during primary hip arthroplasty on brain functions assessed at the biochemical and clinical levels. The S100B protein is a biochemical marker of brain damage. Its plasma concentration was compared with the results of neuropsychological tests, conducted during the perioperative period. PATIENTS AND METHODS: Two groups of patients who underwent primary hip arthroplasty were analyzed; group one (n = 30) with the use of bone cement (cemented), group two (n = 30) without (cementless). All of the procedures were under spinal anesthesia with intravenous sedation. In each group, S100B protein concentration was examined before the surgery and just after the operation, and 6, 24, and 72 h after the procedure. Two neuropsychological tests were conducted before the surgery and 24 and 72 h after. The patients with preexisting blood flow disturbances inside the carotid and vertebral arteries and those with intraoperative mean arterial pressure below 50 mmHg were excluded from the study. STATISTICAL ANALYSIS: Data were analyzed using SPSS 15.0 for Windows (SPSS Inc., Chicago, IL, USA). The two groups were compared using the Mann-Whitney U-test. The comparison between the groups was done with Wilcoxon's signed ranks test. The correlations were analyzed using Spearman's rho test.
RESULTS: There were no significant differences between the two groups in S100B protein concentration before the surgery. Just after the operation, the S100B protein concentration was elevated in both groups, but its level in the cemented group was significantly higher, particularly just after the surgery, and its normalization was slower than in the cementless group. The comparison of time points within each group revealed that there were no significant differences in patients' reaction time in the simple reaction test before and after the surgery (p = 0.056 and 0.163 in the cementless and 0.581 and 0.139 in the cemented groups), but a significantly longer mean reaction time in the choice reaction test was observed within each group after the surgery (p = 0.003 and 0.001 in the cementless and 0.001 and 0.014 in the cemented groups). There were no correlations between S100B protein plasma concentration and the results of the neuropsychological tests.
CONCLUSIONS: There was a relationship between bone cement implantation during primary hip arthroplasty and elevated S100B protein plasma concentration during the short postoperative period, but the results of the neuropsychological tests did not reflect this.

Entities:  

Keywords:  Bone cement; Cognitive dysfunction; Hip arthroplasty; Neuropsychological tests; S100B protein

Year:  2009        PMID: 26815566     DOI: 10.1007/s00068-009-8084-6

Source DB:  PubMed          Journal:  Eur J Trauma Emerg Surg        ISSN: 1863-9933            Impact factor:   3.693


  21 in total

Review 1.  Serum S-100B protein as a molecular marker in severe traumatic brain injury.

Authors:  Andreas Raabe; Olaf Kopetsch; Alina Woszczyk; Josef Lang; Rüdiger Gerlach; Michael Zimmermann; Volker Seifert
Journal:  Restor Neurol Neurosci       Date:  2003       Impact factor: 2.406

2.  Defining postoperative cognitive dysfunction.

Authors:  L S Rasmussen
Journal:  Eur J Anaesthesiol       Date:  1998-11       Impact factor: 4.330

3.  The early recovery of cognitive function after total-hip replacement under hypotensive epidural anesthesia.

Authors:  Nigel E Sharrock; Gabriel Fischer; Selena Goss; Erin Flynn; George Go; Thomas P Sculco; Eduardo A Salvati
Journal:  Reg Anesth Pain Med       Date:  2005 Mar-Apr       Impact factor: 6.288

4.  Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury.

Authors:  M Herrmann; N Curio; S Jost; C Grubich; A D Ebert; M L Fork; H Synowitz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

5.  Intraoperative cerebral arterial embolization during total hip arthroplasty.

Authors:  C R Edmonds; D Barbut; D Hager; N E Sharrock
Journal:  Anesthesiology       Date:  2000-08       Impact factor: 7.892

6.  High serum S100B levels for trauma patients without head injuries.

Authors:  R E Anderson; L O Hansson; O Nilsson; R Dijlai-Merzoug; G Settergren
Journal:  Neurosurgery       Date:  2001-06       Impact factor: 4.654

7.  Playing ice hockey and basketball increases serum levels of S-100B in elite players: a pilot study.

Authors:  Britt-Marie Stålnacke; Yelverton Tegner; Peter Sojka
Journal:  Clin J Sport Med       Date:  2003-09       Impact factor: 3.638

8.  Circulating S100B is increased after bilateral femur fracture without brain injury in the rat.

Authors:  L E Pelinka; L Szalay; M Jafarmadar; R Schmidhammer; H Redl; S Bahrami
Journal:  Br J Anaesth       Date:  2003-10       Impact factor: 9.166

9.  The use of bone cement induces an increase in serum astroglial S-100B protein in patients undergoing total knee arthroplasty.

Authors:  Hiroyuki Kinoshita; Hiroshi Iranami; Keisuke Fujii; Akinori Yamazaki; Manabu Shimogai; Katsutoshi Nakahata; Yasuo Hironaka; Yoshio Hatano
Journal:  Anesth Analg       Date:  2003-12       Impact factor: 5.108

10.  Serum concentrations of two biochemical markers of brain tissue damage S-100B and neurone specific enolase are increased in elite female soccer players after a competitive game.

Authors:  B-M Stålnacke; A Ohlsson; Y Tegner; P Sojka
Journal:  Br J Sports Med       Date:  2006-04       Impact factor: 13.800

View more
  1 in total

Review 1.  Biomarkers of Brain Damage and Postoperative Cognitive Disorders in Orthopedic Patients: An Update.

Authors:  Dariusz Tomaszewski
Journal:  Biomed Res Int       Date:  2015-08-31       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.